Database startup Supabase announced a $500 million funding round that values the company at $10.5 billion, including the fresh capital. Supabase provides back-end technology for vibe coders. "I built ...

Generate:Biomedicines (NASDAQ: GENB), the drug developer focused on creating immunology and inflammation (I&I) and oncology treatments through its own artificial intelligence (AI)-based platform, has ...

Agentic coding workflows are now routinely generating costs that exceed what users pay per month. GitHub’s response, pausing new sign-ups for Pro, Pro+, and Student plans and tightening usage caps, ...

Confirming it has reached 3 million weekly developers, OpenAI is massively updating its Codex developer environment via its Mac and Windows desktop apps today to bring it closer to the “Super App” the ...

For decades, academic institutions have struggled with how to prevent researchers who have committed misconduct from securing jobs at other universities while hiding the bad behaviour. A proposal ...

Microsoft has announced a new generative AI model designed for gameplay ideation. The company detailed what it calls the first World and Human Action Model (WHAM). The WHAM, Katja Hofmann, Senior ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Supabase, a popular developer database platform, has been blocked in India — one of its key markets — TechCrunch has learned. New Delhi ordered internet providers to block its website, resulting in ...

Recently we were introduced to OpenClaw, an AI that allows users to create their own agents to control apps like email, Spotify and home controls. Now, Sam Altman has announced that OpenAI has ...

SQL Server backups cannot be restored to older versions directly. Use Export and Import Data-Tier Application for cross-version database migration. Reconfigure permissions, logins, and connection ...

Generate Biomedicines Inc. filed for an initial public offering, joining a growing list of biotechnology firms to leap to public markets as investors embrace the sector. The Somerville, ...